Use of Real-World Data in Systematic Literature Reviews Conducted for Health Technology Assessment Submissions in Europe

被引：0
|
作者：
Dasari, G. [1 ]
Mulkalapalli, N. [2 ]
Bongale, A. A. [2 ]
Rajput, A. [3 ]
Kamra, S. [3 ]
Gaultney, J. [4 ]
机构：
[1] IQVIA, Hyderabad, AP, India
[2] IQVIA, Bangalore, AP, India
[3] IQVIA, Gurugram, India
[4] IQVIA, London, England
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HTA206
引用
下载
收藏
页码：S337 / S337
页数：1
相关论文
共 50 条
  • [11] Promoting the systematic use of real-world data and real-world evidence for digital health technologies across Europe: a consensus framework
    Srivastava, Divya
    Henschke, Cornelia
    Virtanen, Lotta
    Lotman, Eno-Martin
    Friebel, Rocco
    Ardito, Vittoria
    Petracca, Francesco
    HEALTH ECONOMICS POLICY AND LAW, 2023, 18 (04) : 395 - 410
  • [12] GLOBAL USE OF NORDIC REAL-WORLD EVIDENCE: A SYSTEMATIC REVIEW OF PUBLISHED LITERATURE AND HTA SUBMISSIONS
    Kaushik, P.
    Grip, Toresson E.
    Lueza, B.
    Arya, S.
    Singh, N.
    Nanda, S.
    Grover, R.
    Afaque, A.
    Syal, K.
    VALUE IN HEALTH, 2023, 26 (12) : S531 - S531
  • [13] UNDERSTANDING THE VALUE OF REAL-WORLD EVIDENCE (RWE) IN HEALTH ECONOMICS: ARE TRADITIONAL SYSTEMATIC LITERATURE REVIEWS (SLRS) OMITTING KEY EVIDENCE FOR HEALTH TECHNOLOGY ASSESSMENT (HTA)?
    Richard, M. E.
    Harricharan, S.
    Forsythe, A.
    VALUE IN HEALTH, 2021, 24 : S53 - S53
  • [14] THE USE OF REAL-WORLD DATA IN HEALTH TECHNOLOGY ASSESSMENT OF MEDICATIONS FOR RARE DISEASES IN CANADA AND THE UK
    Mickle, A.
    Harwood, M.
    Deighton, A.
    Qian, C.
    Szabo, S.
    VALUE IN HEALTH, 2020, 23 : S384 - S384
  • [15] The Role of Real-World Data in Single Technology Appraisal Submissions in the United Kingdom
    Waser, Nathalie A.
    Goring, Sarah M.
    Wang, Sisi
    Tao, Rei
    Korol, Ellen E.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 626 - 626
  • [16] THE USE OF EXPERT OPINIONS, PATIENT, AND CARER PERSPECTIVES AND REAL-WORLD EVIDENCE IN ORPHAN DISEASE SUBMISSIONS DIFFERS FOR HEALTH TECHNOLOGY ASSESSMENT AGENCIES ACROSS THE WORLD
    Taieb, Ben A.
    Withers, K.
    Hardy, E. J.
    Swart, N.
    Redhead, G.
    Lang, S. H.
    Foy, C. F.
    Leadley, R. M.
    Swift, S. L.
    VALUE IN HEALTH, 2023, 26 (12) : S325 - S325
  • [17] POLICIES FOR USE OF REAL-WORLD DATA IN HEALTH TECHNOLOGY ASSESSMENT: A COMPARATIVE STUDY OF 6 HTA AGENCIES
    Makady, A.
    ten Ham, R.
    de Boer, A.
    Hillege, J. L.
    Klungel, O.
    Goettsch, W.
    VALUE IN HEALTH, 2016, 19 (07) : A501 - A502
  • [18] TARGETED LITERATURE REVIEW OF THE USE OF REAL-WORLD EVIDENCE FROM SINGLE REAL-WORLD DATA SOURCES AND IN META-ANALYSES: METHODOLOGIES AND RECOMMENDATIONS FROM HEALTH TECHNOLOGY ASSESSMENT BODIES
    Martin, C.
    Diawara, K.
    Jaiswal, A. K.
    Gamburg, R.
    Miller, J.
    Park, C.
    Ranjan, N.
    Mehta, A. M.
    Tamminina, D.
    Shah, T.
    Schmerold, L.
    Hood, D.
    VALUE IN HEALTH, 2024, 27 (06) : S14 - S15
  • [19] WHAT USE IS DISTRIBUTED LEDGER TECHNOLOGY IN REAL-WORLD PRACTICE? - A SYSTEMATIC LITERATURE REVIEW
    Abogunrin, S.
    Koufopoulou, M.
    Arregui, M.
    Lovelace, M.
    Arisa, O.
    VALUE IN HEALTH, 2018, 21 : S172 - S172
  • [20] The (Harsh) Reality of Real-World Data External Comparators for Health Technology Assessment
    Cox, Oliver
    Sammon, Cormac
    Simpson, Alex
    Wasiak, Radek
    Ramagopalan, Sreeram
    Thorlund, Kristian
    VALUE IN HEALTH, 2022, 25 (07) : 1253 - 1256
12345